Maryam Sadat Mirenayat

Evaluation of adalimumab effects in managing severe cases of COVID-19: A randomized controlled trial

Atefeh Fakharian, Saghar Barati, Maryam Sadat Mirenayat et al. · International Immunopharmacology · 2021 · 34 citations · Full text

Disease Management, Covid-19 Pandemic, Clinical Trials +6

Association Between Vitamin D Deficiencies in Sarcoidosis with Disease Activity, Course of Disease and Stages of Lung Involvements

Arda Kiani, Atefeh Abedini, Ian M. Adcock et al. · Journal of Medical Biochemistry · 2017 · 29 citations · Full text

Fungal epidemiology in cystic fibrosis patients with a special focus on Scedosporium species complex

Mohammad Taghi Hedayati, Mahin Tavakoli, Maedeh Maleki et al. · Microbial Pathogenesis · 2019 · 29 citations

Cystic Fibrosis Patients, Pathogenesis, Special Focus +7

What Do We Know about Anthracofibrosis? A Literature Review.

Hamidreza Jamaati, Amirsina Sharifi, Maryam Sadat Mirenayat et al. · PubMed · 2017 · 22 citations · Full text

Asthma, Pathology, Single Syndrome +17

Combination therapy of IFNβ1 with lopinavir–ritonavir, increases oxygenation, survival and discharging of sever COVID-19 infected inpatients

Parvaneh Baghaei, Farzaneh Dastan, Majid Marjani et al. · International Immunopharmacology · 2020 · 17 citations · Full text

Sever Covid-19, Immunology, Antiviral Response +10